Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells

Lee, SD; Yu, D; Lee, DY; Shin, HS; Jo, JH; Lee, YC

Lee, YC (reprint author), Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea.

CANCER SCIENCE, 2019; 110 (2): 662

Abstract

Cisplatin is a well-known anticancer drug used to treat various cancers. However, development of cisplatin resistance has hindered the efficiency of t......

Full Text Link